111 (YI) Profit After Tax Growth (3y) (2020 - 2025)
111 (YI) Profit After Tax Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 30.95% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 56.50% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 1.35% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -5.80% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 35.78% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -4.01% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 60.53% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -82.72% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.53% |
| Sep 30, 2025 | 74.42% |
| Jun 30, 2025 | 56.88% |
| Mar 31, 2025 | 60.19% |
| Dec 31, 2024 | 52.43% |
| Sep 30, 2024 | 73.19% |
| Jun 30, 2024 | 78.46% |
| Mar 31, 2024 | 75.68% |
| Dec 31, 2023 | -11.14% |
| Sep 30, 2023 | 11.27% |
| Jun 30, 2023 | 21.97% |
| Mar 31, 2023 | 45.82% |
| Dec 31, 2022 | -38.62% |
| Sep 30, 2022 | -39.24% |
| Jun 30, 2022 | -41.99% |
| Mar 31, 2022 | -42.59% |
| Dec 31, 2021 | -42.11% |
| Sep 30, 2021 | -50.34% |
| Jun 30, 2021 | -27.79% |
| Mar 31, 2021 | -57.10% |